|Systematic (IUPAC) name|
3,6α-dihydroxy- 4,5α-epoxy- 7,8-didehydromorphinan
|Molar mass||271.311 g/mol[[Script error: No such module "String".]]|
Normorphine has relatively little opioid activity in its own right, but is a useful intermediate which can be used to produce both opioid antagonists such as nalorphine, and also potent opioid agonists such as N-phenethylnormorphine. It is also produced as a major metabolite of morphine, with its formation from morphine catalysed by the liver enzymes CYP3A4 and CYP2C8.
Cite error: Invalid
parameter "group" is allowed only.
<references />, or
<references group="..." />
- Fraser HF, Wikler A, Van Horn GD, Eisenman AJ, Isbell H. Human pharmacology and addiction liability of normorphine. Journal of Pharmacology and Experimental Therapeutics. 1958 Mar;122(3):359-69. PMID 13539761
- Lasagna L, De Kornfeld TJ. Analgesic potency of normorphine in patients with postoperative pain. Journal of Pharmacology and Experimental Therapeutics. 1958 Nov;124(3):260-3. PMID 13588540
- Daniel Lednicer. Central Analgetics. (1982), p146. ISBN 0-471-08314-3
- Yeh SY. Urinary excretion of morphine and its metabolites in morphine-dependent subjects. Journal of Pharmacology and Experimental Therapeutics. 1975 Jan;192(1):201-10. PMID 235634
- Projean D, Morin PE, Tu TM, Ducharme J. Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes. Xenobiotica. 2003 Aug;33(8):841-54. PMID 12936704